Reaction

Seroma reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,257 reports · 25 co-occurring drugs

As of the last recalculation, Seroma appears in 1,257 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is AMIODARONE HYDROCHLORIDE (PRR 39.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Amiodarone Hydrochloride2639.239.3
Bupivacaine1934.234.2
Pertuzumab3018.718.7
Valsartan Oral5015.815.8
Basiliximab1115.615.6
Torsemide3015.315.4
Trastuzumab6015.115.2
Lactulose3314.614.6
Abemaciclib1714.314.3
Valganciclovir1412.412.4
Valganciclovir Hydrochloride1412.412.4
Sodium Chloride Tablet5111.911.9
Sodium Chloride Tablets5111.911.9
Exemestane1511.711.7
Sodium Chloride5311.611.6
Diclofenac Sodium 1%2411.311.3
Diclofenac Sodium Topical2411.311.3
Diclofenac Sodium Topical Gel, 1%2411.311.3
Paclitaxel (Aibumin-Bound)459.49.4
Paclitaxel467.97.9
Conjugated Estrogens And Medroxyprogesterone Acetate117.87.8
Docetaxel Anhydrous266.56.5
Docetaxel266.56.5
Abiraterone56.16.1
Pegfilgrastim244.14.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.